12 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33907665 | Indomethacin: Can It Counteract Bradykinin Effects in COVID-19 Patients? | 2021 | 1 |
2 | 21612106 | [Nonsteroidal antirheumatics and hypertension]. | 2011 Mar-Apr | 1 |
3 | 16004891 | Angiotensin-converting enzyme inhibitors reveal non-NO-, non-prostacycline-mediated endothelium-dependent relaxation in internal thoracic artery of hypertensive patients. | 2005 Jul 20 | 2 |
4 | 12494116 | [Interaction of angiotensin converting enzyme inhibitors with nonsteroidal antiinflammatory drugs]. | 2002 | 1 |
5 | 10828759 | Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy. | 2000 Apr | 1 |
6 | 11078175 | Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. | 2000 Nov | 2 |
7 | 9848785 | The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin. | 1998 Dec | 1 |
8 | 9853274 | Effect of indomethacin on the renal response to angiotensin II receptor blockade in healthy subjects. | 1998 Dec | 1 |
9 | 9060089 | PGE2 production after angiotensin-converting enzyme inhibition. | 1997 Feb | 2 |
10 | 9289376 | [The antagonistic effect of aspirin on the expression of prostaglandin participation in the antihypertensive activity of ACE inhibitors]. | 1997 Jun | 2 |
11 | 2175149 | Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril. | 1990 | 2 |
12 | 3005063 | [Clinical significance of serum angiotensin I-converting enzyme in essential hypertension]. | 1985 Dec 20 | 1 |